pharmaphorum

MARCH 24, 2022

In the latest episode of the pharmaphorum podcast, editor in chief Jonah Comstock speaks with Miruna Sasu, chief strategy officer of COTA and long-time pharma vet– before joining COTA last year, she headed up J&J’s Clinical Trial Feasibility and Advanced Analytics Team and led the Digital Health and Innovation Team at Bristol Myers Squibb.

Big Data 52

Big Data Clinical Trials Clinical Trials Trials 52

Rethinking Clinical Trials

AUGUST 16, 2023

Landry is a professor of medicine and epidemiology at Oxford Population Health and deputy director of the University of Oxford’s Big Data Institute. The post August 16, 2023: In This Friday’s PCT Grand Rounds, the Draft Revision of the ICH Good Clinical Practice Guideline appeared first on Rethinking Clinical Trials.

Clinical Trials 130

Clinical Trials Clinical Trials Big Data Trials 130

pharmaphorum

MAY 30, 2022

Josh Sackman, president and co-founder of AppliedVR, and Web Sun, president and co-founder of Komodo Health, relay how their newly formed collaboration reshapes the clinical trial process by using data, helping to cut costs and allowing for evaluation of broader patient populations. .

Clinical Trials 87

Clinical Trials Clinical Trials Trials Big Data 87

pharmaphorum

FEBRUARY 1, 2022

Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges of running clinical trials. Can the combined potential of new AI technologies and real-world patient data hold the key to overcoming the challenges in clinical trial design that have historically led to trial failure?

Clinical Trials 94

Clinical Trials Clinical Trials Trials Engineer 94

Pharmaceutical Technology

JANUARY 16, 2023

The report also suggested that Big Data was thought to be the most important partner to AI, in terms of introducing technology-related changes in the pharmaceutical sector (Figure 2). AI has been voted as the most disruptive emerging technology every year since 2020, according to the survey tracker.

Big Data 303

Big Data Pharma Companies Clinical Trials Clinical Trials 303

Crucial Data Soutions

NOVEMBER 9, 2021

A paradigm shift is occurring in the clinical trials industry surrounding mobile technology, or more specifically, mobile health (mHealth) following the COVID-19 pandemic. Organizations are beginning to recognize the power mHealth has to positively affect their clinical trials and are implementing technologies at an increasing rate.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Big Data 52

Drug Discovery World

JULY 11, 2023

For example, Sanofi, Pfizer, Gilead, Novartis, BMS, Genentech, and Bayer have all announced significant alliances to integrate these big data technologies into drug discovery operations. Clinical Decision Support Software, Guidance for Industry and Food and Drug Administration Staff Document issued on September 28, 2022.

Big Data 40

Big Data Development Life Science Drugs 40

pharmaphorum

JULY 14, 2022

A pilot study has been launched by the EMA to see whether it is helpful for regulators to look at the ‘raw data’ from clinical trials submitted in support of new marketing application along with the usual structured analyses from sponsors.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Regulation 52

AuroBlog - Aurous Healthcare Clinical Trials blog

MARCH 15, 2023

Some of the medical advances with the technology are genomics and epigenetics, Big Data, AI and ML which are allowing molecular […] Technology adoptions like artificial intelligence and machine learning are bringing in major transformation in the way a primary physician will extend treatment protocols.

Big Data 100

Big Data Genome Genomics Clinical Trials 100

Rethinking Clinical Trials

JUNE 29, 2022

Big data; Real-word evidence; Real-world data; 21st Century Cures Act; FDA Draft Guidance. Big Data, a term first used in the 1990s, leverages modern technology to increase the quantity, forms, speed, and capability to manipulate large-scale data. Office of Medical Policy (OMP). Key Points.

Big Data 130

Big Data Clinical Trials Clinical Trials Drugs 130

Rethinking Clinical Trials

JUNE 7, 2023

Shirley Wang In this Friday’s PCT Grand Rounds, Shirley Wang of Harvard Medical School will present “Emulating Randomized Clinical Trials With Non-randomized Real-World Evidence Studies: Results From the RCT DUPLICATE Initiative.” Join the online meeting.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Medicine 130

pharmaphorum

APRIL 22, 2021

This pharmaphorum webinar, held in association with Savana, will take place on Thursday 22 April from 16:00-17:00 BST / 17:00-18:00 CET / 10:00-11:00 EST and hear from presenters at BREATHE - the Health Data Research Hub for Respiratory Health, Salford Royal NHS Foundation Trust and Savana.

Big Data 52

Big Data Research Development Clinical Trials 52

Rethinking Clinical Trials

JULY 14, 2022

The post July 14, 2022: Grand Rounds Podcast Now Available, Featuring Dr. John Concato on FDA Draft Guidance on Real-World Evidence appeared first on Rethinking Clinical Trials. Concato is also available.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Big Data 130

Crucial Data Soutions

JUNE 12, 2019

Too many life-saving treatments and medical advancements are at stake to remain attached to the traditional ways of data collection. Over the past ten years, we’ve seen things slowly going the way of virtual clinical trials. The benefits of virtual trials are numerous, and we’ll cover many of them in this blog post.

Clinical Trials 40

Clinical Trials Clinical Trials Trials Research 40

BioTech 365

NOVEMBER 22, 2021

Red Cell Forms Zephyr AI to Revolutionize Drug Discovery and Precision Medicine Red Cell Forms Zephyr AI to Revolutionize Drug Discovery and Precision Medicine Zephyr AI Applies Artificial Intelligence and Big Data to Advance Drug Development, Streamline Clinical Trials, and … Continue reading →

Medicine 52

Medicine Big Data Drugs Clinical Trials 52

The Pharma Data

JANUARY 12, 2021

a leader in precision medicine and artificial intelligence (AI)-enabled patient-centric oncology clinical trial enrollment, announced today it has launched its SYNERGY-AI Oncology Clinical Trial Command Center (OCTCC) with the mission to disrupt and accelerate the clinical trial enrollment process.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Clinical Research 52

ACRP blog

APRIL 5, 2023

AI is increasingly important in drug discovery and development as well as clinical trials, operations, pharmacovigilance, and many other areas.” This has led to the emergence of a new ‘pharmaceutical intelligence’ that has allowed the industry to move away from traditional, slow-moving, and costly processes,” Lyons writes. “AI

Big Data 52

Big Data Clinical Trials Clinical Trials Life Science 52

Rethinking Clinical Trials

JUNE 26, 2023

The post June 26, 2023: NIMHD Director Discusses Ways Researchers Can Help Reduce Health Disparities appeared first on Rethinking Clinical Trials. Stay tuned for more interviews with program leaders from the 2023 Steering Committee meeting.

Research 130

Research Big Data Clinical Research Trials 130

Roots Analysis

APRIL 4, 2023

In addition to the advances in processing power of computing machines and the development of smarter algorithms, big data is considered to be one of the key drivers of growth in this segment. Big data holds great promise in terms of its potential applications in the healthcare industry as mentioned below.

Big Data 52

Big Data Life Science Development Clinical Trials 52

pharmaphorum

DECEMBER 10, 2020

UK digital health firm Sensyne has secured access to millions more anonymised patent records via an alliance with US clinical trial data specialist Phesi. The new agreement comes after a string of access deals with NHS trusts for patient data, and coincides with a bid by Sensyne to raise £27.5

Clinical Trials 95

Clinical Trials Clinical Trials Big Data Trials 95

pharmaphorum

NOVEMBER 24, 2022

Two years ago, the EMA proposed a set of recommendations to unlock the potential of big data for public health, headlined by the creation of a platform to access and analyse healthcare data from across the bloc. With the first data partners on board, the regulator can now move ahead with the start of its first studies.

Big Data 52

Big Data Biobanking Regulation Medicine 52

Drug Discovery World

DECEMBER 20, 2022

There will be greater emphasis on diversity in clinical trials. A focus on the representation of diverse patient populations in clinical trials will be a very good thing for the industry, but could be challenging. DDW’s Diana Spencer summarises the key trends likely to impact the market in 2023. .

Drugs 52

Drugs Gene Editing Clinical Trials Clinical Trials 52

Drug Discovery World

AUGUST 24, 2023

This is the latest episode of the free DDW narrated podcast, “What lies in the future for genomics and big data?”, ”, which covers two articles written for Volume 23, Issue 3 – Summer 2022 of DDW. They are called “ US biotech: Focus on positive growth and innovation ”, and “ Sitting down with Calidi Biotherapeutics ”.

Big Data 52

Big Data Drugs Genome Genomics 52

pharmaphorum

SEPTEMBER 16, 2022

It was a time when “the potential for systematic understanding of complex biology was palpable”, a fascinating terrain wherein the “first bacterial genomes were being sequenced”, when microarray technology was in the early stages of being invented, and ‘genomics’ and ‘big data’ certainly weren’t on the tips of people’s tongues.

Development 130

Development Research Drugs Clinical Trials 130

pharmaphorum

JANUARY 24, 2022

AI in drug discovery is becoming an integral part of the research and development area of treating diseases with more companies incorporating ‘Big Data’ and data scientists within their R&D teams. Learn about the new breakthroughs within clinical trials and the treatment of disease. Who Should Attend?

Drugs 52

Drugs Big Data Scientist Clinical Trials 52

ECRG Media's Clinical Research Podcast

APRIL 15, 2018

The big headline out of the health care M&A world today is Swiss pharmaceutical giant Roche’s $1.9 billion acquisition of Flatiron Health, the Alphabet-backed, cancer-focused digital health analytics upstart that’s attempting to use real world patient information and big data to spur better oncology R&D.

Big Data 52

Big Data Clinical Trials Clinical Trials Trials 52

ECRG Media's Clinical Research Podcast

APRIL 15, 2018

The big headline out of the health care M&A world today is Swiss pharmaceutical giant Roche’s $1.9 billion acquisition of Flatiron Health, the Alphabet-backed, cancer-focused digital health analytics upstart that’s attempting to use real world patient information and big data to spur better oncology R&D.

Big Data 52

Big Data Clinical Trials Clinical Trials Trials 52

pharmaphorum

OCTOBER 12, 2021

Meanwhile, bumetanide exposure was associated with a 35% to 75% lower Alzheimer’s prevalence in individuals over the age of 65 years in two electronic health record databases, suggesting bumetanide could play a role in preventing the disease.

Gene Expression 111

Gene Expression Drugs FDA Approval Gene 111

Roots Analysis

DECEMBER 29, 2023

Clinical trials are prospective biomedical research studies designed to evaluate medical, surgical or behavioral interventions in people and investigate novel approaches for the diagnosis and prevention / treatment of diseases. Clinical research can be classified into two types: observational studies and clinical trials.

Clinical Trials 40

Clinical Trials Clinical Trials Trials Research 40

Drug Discovery World

DECEMBER 27, 2023

Ng is working on critical challenges in clinical trials, specifically in planning and recruitment, and has been building innovative solutions designed to benefit patients and researchers – with a focus on efficiency, transparency and diversity in clinical development. Listen here. Listen here.

Clinical Trials 69

Clinical Trials Clinical Trials Drugs Development 69

XTalks

OCTOBER 18, 2022

Using the big data from our HFX Cloud patient database, our unique HFX Algorithm was developed to identify those programs where patients have been more likely to get relief in the real world. “HFX iQ is designed to improve the consistency of pain relief and is the only SCS system that truly personalizes care,” said D.

FDA Approval 98

FDA Approval Big Data Life Science Clinical Trials 98

Drug Discovery World

OCTOBER 12, 2022

Having these new data leads to greater understanding and enables precision medicine. . Why are digital biomarkers important in clinical trials? . The foremost consideration when choosing sensor technology is to ensure that it is fit-for-purpose and will provide the clinical evidence required for the study.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Sales 52

Placebo Control

MARCH 18, 2014

Next, I was invited to be a guest blogger for the upcoming Partnerships in Clinical Trials Conference. Will Big Data Save Us from Ourselves? Will Big Data Save Us from Ourselves? - FPI is dedicated to an open discussion of patient recruitment ideas, and I’m extremely proud of what we've published so far.

Big Data 40

Big Data Clinical Trials Clinical Trials Trials 40

Drug Discovery World

FEBRUARY 6, 2023

Johannes Goll, Global Head of Emmes’ Biomedical Data Science and Bioinformatics department, explains how big data analytics can deliver improved therapies and bring clinical research one step close to realising the potential of personalised care.

Big Data 52

Big Data RNA Bioinformatics Vaccination 52

pharmaphorum

MAY 4, 2021

These include digital sales and marketing, virtual clinical trials, and the continued maturation of telehealth – as well as the directions in data to follow. In the white paper, expert contributors share a detailed picture of the digital trends with the greatest potential to impact the near future.

Clinical Trials 89

Clinical Trials Clinical Trials Sales Trials 89

pharmaphorum

MAY 25, 2021

They allow them to study the development of disease in a group of patients that are more representative of the general population than in a typical clinical trial, giving a more nuanced view of the performance of the therapy’s benefits and drawbacks. Patient-friendly studies. About Savana.

Big Data 131

Big Data Clinical Research Research Trials 131

Drug Discovery World

JULY 20, 2023

The reflection paper is part of the joint HMA-EMA Big Data Steering Group (BDSG) initiatives to develop the European Medicines Regulatory Network’s capability in data-driven regulation. In clinical trials, AI/ML systems may support the selection of patients based on certain disease characteristics or other clinical parameters.

Drugs 40

Drugs Regulation Medicine Big Data 40